Abstract The most well-known type of focal epilepsy that is resistant to existing treatments is temporal lobe epilepsy (TLE), with seizure foci in various structures including temporal lobe, hippocampus, amygdala, entorhinal cortex, and subcortex
It replaces variable flat per-compound pricing with predictable monthly fees, unlike traditional insurance copay or retail pharmacy models
But some doctors, psychologists and eating disorder experts worry these new medications, originally developed to treat diabetes, could become a problem long-term
As these treatments become more popular, theyre changing how the industry approaches chronic diseasebringing both fresh opportunities but also new challenges
The process begins with a thorough New Patient Visit, where we conduct a detailed assessment to understand your unique health needs and goals